ITeos Therapeutics Inc’s filing revealed that its Chief Executive Officer Detheux Michel unloaded Company’s shares for reported $0.44 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
ITeos Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Gall Matthew acquired Company’s shares for reported $38635.0 on